550
views
0
recommends
+1 Recommend
1 collections
    59
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Economic burden of inpatients with viral hepatitis B-related diseases and the influencing factors

      research-article

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective: The purpose of this study was to analyze the economic burden of inpatients with hepatitis B virus (HBV)-related diseases and the influencing factors so as to provide an effective basis for the development of health prevention and control strategies.

          Methods: The patients were selected by means of successive sampling in the period between August and December 2012 from those who were diagnosed with HBV-related diseases and hospitalized in county-level medical institutions of Jiangsu Province. One hundred ninety-six patients were studied, including 3 patients with acute HBV, 141 with chronic HBV, 18 with compensatory cirrhosis, 22 with decompensated cirrhosis, and 12 with liver cancer. This study adopted a questionnaire method to investigate and calculate the direct and indirect economic burden of the subjects according to disease economic burden theories and methods. Multiple linear stepwise regression was used for analysis of the influencing factors for economic burden of inpatients with HBV-related diseases.

          Results: The average economic burden for the 196 inpatients investigated was RMB 28,971. The direct economic burden was RMB 19,916 (68.7%), including direct medical costs (RMB 19,087; 95.8%) and direct non-medical costs (RMB 829; 4.2%). The indirect economic burden was RMB 9055 (31.3%), including patient-related expenses (RMB 6348; 70.1%) and nursing expenses (RMB 2707; 29.9%). According to the multiple linear stepwise regression analysis results, the hospital stay, proportion of medicine, age, and disease type affected the economic burden of the patients ( P<0.05).

          Conclusion: Patients with HBV-related diseases undertake a heavy economic burden for hospitalization, especially the direct economic burden. Therefore, the inpatients’ economic burden can be reduced by shortening the hospital stay, reducing the medical expenses reasonably, and delaying the progression of disease as far as possible according to medical standards.

          Related collections

          Most cited references 9

          • Record: found
          • Abstract: not found
          • Article: not found

          Analysis on the economic burden of patients with hepatitis B-related diseases and the influencing factors in Shenzhen

           L Sen,  S Zhang,  Q Ma (2010)
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The societal burden of HBV- related disease; South Korea

             BM Yang,  DJ Kim,  KS Byun (2010)
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              How big is the financial burden of hepatitis B ti society? A cost – of – illness study of hepatitis B infection in Singapore

               SC Ong,  SG Lim,  SC Li (2009)
                Bookmark

                Author and article information

                Journal
                FMCH
                Family Medicine and Community Health
                FMCH
                Family Medicine and Community Health & American Chinese Medical Education Association (USA )
                xxx-xxx
                2305-6983
                December 2013
                December 2014
                : 1
                : 4
                : 31-35
                Affiliations
                [1] 1School of Public Health of Southeast University, Nanjing, Jiangsu 210009, China
                [2] 2Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu 210009, China
                Author notes
                CORRESPONDING AUTHOR: Pei Liu, School of Public Health of Southeast University, Nanjing, Jiangsu 210009, China, E-mail: liupeiseu@ 123456126.com
                Funding: National Science and Technology Major Project – Study on Large-scale Field Epidemiology and Interventions for AIDS Prevention, Virus Hepatitis, Tuberculosis and other Major Infectious Diseases [2011ZX10004902]; Jiangsu Center for Disease Control and Prevention, Foundation for Industry depending on Science and Technology – Study on the Establishment and Verification of Standard Treatment Financing Model for Patients with Chronic Hepatitis B
                Article
                fmch20140114
                10.15212/FMCH.2014.0114
                022c158d-0bd1-47f2-b019-f6a94df1741e
                Copyright © 2013 Family Medicine and Community Health

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 Unported License (CC BY-NC 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc/4.0/.

                Product
                Self URI (journal page): http://fmch-journal.org/
                Categories
                Original Research

                Comments

                Comment on this article